Loading...

NEXTGEN COLOCORE TARGETED PANEL MSI ( PCR)

image not found

 NABL Cap Accredited 
The NextGen ColoCore Targeted Panel MSI (PCR) at Metropolis Healthcare is a specialized molecular test designed to detect Microsatellite Instability (MSI), an important biomarker in colorectal and certain other cancers. This test helps identify defects in DNA mismatch repair pathways using sensitive PCR-based methods. Metropolis Healthcare ensures high analytical precision, supporting clinicians in treatment planning, prognosis assessment, and immunotherapy decision-making. It is especially useful for patients diagnosed with colorectal cancer or those being evaluated for hereditary cancer risk

  • 17 Crores+ Samples Processed
  • World Class Technology Labs
  • 25+ Years of Trust & Experience
  • Free Home Collection

Price: Rs. 22,000.00

Sample Type: EDTA Whole Blood

Fasting Not Required


Frequently Asked Questions (FAQ's):

 What does the NextGen ColoCore MSI (PCR) panel include?

It analyzes specific microsatellite markers to determine MSI-High, MSI-Low, or MSS (stable) status.

Why is MSI testing important?
MSI status helps guide prognosis, treatment choices, and eligibility for immunotherapy in colorectal and related cancers.

Who should take this test?
Patients with confirmed or suspected colorectal cancer, Lynch syndrome evaluation, or those requiring biomarker-based therapy guidance may benefit.

How does Metropolis Healthcare perform this test?
Metropolis Healthcare uses advanced PCR-based amplification and fragment analysis to accurately detect microsatellite instability.

What type of sample is required?
Tumor tissue (FFPE block or slides) is typically needed for MSI analysis.

Is any special preparation required?
No preparation is required, but providing adequate tumor tissue is essential for accurate testing.

How soon are the results available?
Metropolis Healthcare usually delivers results promptly to support timely oncological decisions.

Can this test influence treatment options?
Yes, MSI-High tumors often respond well to certain immunotherapies, making this test critical for personalized treatment planning

OUR corporates PARTNER

Feedback

Patient's Testimonials

Trusted by Thousands

OUR Accreditations

OUR Lab